Ampliphi Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.09.17	Stock Performance Review on Biotech Industry -- Intrexon, Ampio Pharma, AmpliPhi Biosciences, and CorMedix (PR Newswire)
25.07.17	Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma (PR Newswire)
26.01.17	Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, and AmpliPhi Biosciences (PR Newswire)
01.11.16	AmpliPhi Biosciences Granted Small and Medium Enterprise Status by European Medicines Agency (Businesswire)
12.04.16	AmpliPhi Biosciences Presents Data Showing Bacteriophage Product Candidate Kills Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients (Businesswire)
08.01.16	AmpliPhi Acquires Key Bacteriophage Assets from UK-based Novolytics (Businesswire)
19.11.15	AmpliPhi Signs Clinical Trial Agreement with University of Adelaide to Conduct a Phase I Trial of Bacteriophage Therapy for Treating Staphylococcus aureus Infections (Businesswire)
10.11.15	AmpliPhi Announces Board Expansion with Appointment of Two Highly-Experienced Non-Executive Directors (Businesswire)
18.09.15	AmpliPhi Announces Data Demonstrating Efficacy of a Novel Bacteriophage Cocktail is Comparable to Vancomycin in S. aureus Lung Infection Model (Businesswire)
08.09.15	AmpliPhi Biosciences to Present at Rodman & Renshaw 17th Annual Global Investment Conference (Businesswire)
02.09.15	AmpliPhi Biosciences Announces Appointment of Alexander Gaidamaka as Vice President of Chemistry, Manufacturing and Control (Businesswire)
18.08.15	AmpliPhi Biosciences Announces Approval of Common Stock Listing on NYSE MKT (Businesswire)
30.07.15	AmpliPhi to Present Research on Efficacy of a Novel Bacteriophage Cocktail in S. aureus Lung Infection Model at ICAAC/ICC 2015 (Businesswire)
12.06.15	AmpliPhi Announces New Data Demonstrating Anti-Pseudomonal Bacteriophages Retained Biological Activity Following Nebulization (Businesswire)
08.06.15	AmpliPhi to Present New Data on Biological Activity of Nebulized Anti-Pseudomonal Bacteriophage (Businesswire)
03.06.15	AmpliPhi’s Bacteriophage Manufacturing Facility Receives cGMP Certification (Businesswire)
31.03.15	AmpliPhi Granted European Patent for Bacteriophage Therapy to Fight Biofilm-related Bacterial Infections (Businesswire)
10.03.15	AmpliPhi BioSciences Corporation Announces $13 Million Financing (Businesswire)
06.01.15	AmpliPhi Provides Shareholder Update (Businesswire)
31.12.14	AmpliPhi BioSciences to Host Shareholder Update Conference Call (Businesswire)
19.09.14	AmpliPhi Announces Departure of CEO (Businesswire)
22.05.14	AmpliPhi Announces Appointment of New Board Member (Businesswire)
01.04.14	AmpliPhi to Present at 13th Annual Needham Healthcare Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ampliphi Biosciences Corp.

Aktien Top/Flop

Meistgelesene Nachrichten